Clinical Trials Sponsored by Medtronic Vascular

Total 1926 results

Medtronic Vascular
Medtronic

Terminated

Single-arm Study of Symplicity™ Renal Denervation System in Patients With Uncontrolled HyperTensioN in India (HTN-India)

Adults With Uncontrolled Hypertension

India
Medtronic Vascular

Completed

SPYRAL PIVOTAL - SPYRAL HTN-OFF MED Study

Cardiovascular Diseases | Vascular Diseases | Hypertension

United States, Canada, Germany, Australia, United Kingdom, Ireland, Japan, Austria, Greece
Medtronic Vascular

Completed

A Single Arm Trial With Resolute Onyx in ONE-Month DAPT for High-Bleeding Risk Patients Who Are Considered One-Month Clear (Onyx ONE Clear) (Onyx ONE Clear)

Coronary Artery Disease

United States
Medtronic Vascular

Completed

Medtronic RevElution Trial (RevElution)

Coronary Artery Disease

Australia, Singapore, Brazil
Medtronic Vascular

Completed

The PREVAIL Study (PREVAIL)

Coronary Artery Disease | Ischemic Heart Disease | In-stent Restenosis

Italy, Belgium, Netherlands
Medtronic Vascular

Completed

Medtronic Resolute Onyx 2.0 mm Clinical Study

Coronary Artery Disease

United States
Medtronic Vascular

Completed

Resolute Integrity US Extended Length Sub-Study(RI US XL) (RI-US XL)

Coronary Artery Disease

United States
Medtronic Vascular

Completed

An Evaluation of the Commercially Available Medtronic Resolute Integrity Zotarolimus-Eluting Coronary Stent System (RI-US)

Coronary Artery Disease

United States
Medtronic Vascular

Completed

Renal Denervation by MDT-2211 System in Patients With Uncontrolled Hypertension (HTN-J)

Uncontrolled Hypertension

Japan
Medtronic Vascular

Completed

The Medtronic RESOLUTE US Clinical Trial (R-US)

Coronary Artery Disease

United States
Medtronic Vascular

Completed

Stable Angina Observational Registry (STAR)

Stable Angina

India
Medtronic Vascular

Completed

Sprinter Legend Balloon Catheter

Coronary Artery Disease

United States
Medtronic Vascular

Recruiting

Global SYMPLICITY Registry (GSR) DEFINE

Hypertension

Germany
Medtronic Vascular

Active, not recruiting

RESOLUTE ONYX China RCT Study

Cardiovascular Diseases | Coronary Artery Disease | Arteriosclerosis | Ischemic Heart Disease | Stenotic Coronary Lesion

China
Medtronic Vascular

Completed

RESOLUTE ONYX Post-Approval Study (ONYX PAS)

Coronary Artery Disease

United States, Belgium, France, Slovakia
Medtronic Vascular

Completed

China Resolute Integrity 34/38 mm Study

Cardiovascular Diseases | Coronary Artery Disease | Arteriosclerosis | Ischemic Heart Disease | Stenotic Coronary Lesion

China
Medtronic Vascular

Completed

A Randomized Controlled Trial With Resolute Onyx in One Month Dual Antiplatelet Therapy (DAPT) for High-Bleeding Risk Patients (Onyx ONE)

Coronary Artery Disease

Korea, Republic of, Spain, Australia, Hong Kong, United Kingdom, Singapore, Thailand, Belgium, New Zealand, Sweden, France, Switzerland, Netherlands, Italy, Slovakia, Lithuania, Austria, Malaysia, Bulgaria, Ireland, Latvia, Norway, ...
Medtronic Vascular

Completed

Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study

Coronary Artery Disease

United States
Medtronic Vascular

Completed

RESOLUTE China Registry: (R-C Registry)

Cardiovascular Diseases | Coronary Artery Disease | Arteriosclerosis | Ischemic Heart Disease | Stenotic Coronary Lesion

China
Medtronic Vascular

Completed

RESOLUTE China RCT (R-China RCT)

Cardiovascular Diseases | Coronary Artery Disease | Arteriosclerosis | Ischemic Heart Disease | Stenotic Coronary Lesion

China
Medtronic Vascular

Completed

RESOLUTE Japan SVS: The Clinical Evaluation of the MDT-4107 DES in the Treatment of De Novo Lesions in Small Diameter Native Coronary Arteries (RJ-SVS)

Myocardial Ischemia | Cardiovascular Diseases | Coronary Artery Disease | Arterial Occlusive Diseases

Japan
Medtronic Vascular

Completed

RESOLUTE Asia: Evaluation of the Endeavor Resolute Zotarolimus-Eluting Stent System in a Patient Population With Long Lesion(s) and/or Dual Vessels in Asia (R-A)

Cardiovascular Diseases | Coronary Artery Disease | Arteriosclerosis | Ischemic Heart Disease | Coronary Stenosis

India
Medtronic Vascular

Completed

Renal Denervation in Patients With Uncontrolled Hypertension (Symplicity HTN-2) (HTN-2)

Uncontrolled Hypertension

Spain, Australia, Germany, France, Latvia, United Kingdom, Belgium, Austria, Poland, Switzerland
Medtronic Vascular

Completed

PROTECT Continued Access Post Marketing Surveillance Trial (PROTECT-CA)

Coronary Artery Disease, Autosomal Dominant, 1

United States
Medtronic Vascular

Completed

Renal Denervation in Patients With Refractory Hypertension

Hypertension

Australia, Poland
Medtronic Vascular

Completed

Renal Denervation in End Stage Renal Disease Patients With Refractory Hypertension

Kidney Failure, Chronic | Renal Dialysis

United States
Medtronic Vascular

Completed

The ENDEAVOR Pharmacokinetic (PK) Registry: The Medtronic Endeavor Drug Eluting Coronary Stent System (ENDEAVOR PK)

Coronary Artery Disease

United States
Medtronic Vascular

Completed

The ENDEAVOR IV Clinical Trial: A Trial of a Coronary Stent System in Coronary Artery Lesions (ENDEAVOR IV)

Coronary Artery Disease

United States
Medtronic Vascular

Completed

The Medtronic RESOLUTE Clinical Trial

Coronary Artery Disease

Australia
Medtronic Vascular

Completed

The Medtronic Endeavor III Drug Eluting Coronary Stent System Clinical Trial (ENDEAVOR III)

Coronary Artery Disease
Medtronic Vascular

Completed

The ENDEAVOR II Clinical Trial: The Medtronic Endeavor Drug Eluting Coronary Stent System in Coronary Artery Lesions (ENDEAVOR II)

Ischemia | Myocardial Ischemia | Heart Diseases | Vascular Diseases | Coronary Artery Disease | Coronary Disease | Arteriosclerosis | Arterial Occlusive Diseases | Coronary Arteriosclerosis

France
Medtronic Vascular

Recruiting

SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN

Cardiovascular Diseases | Vascular Diseases | Hypertension | Diabetes Mellitus | Chronic Kidney Diseases

United States, Monaco, Australia, Germany, France, United Kingdom, Belgium, Netherlands, Sweden, Greece
Medtronic Vascular

Completed

SPYRAL DYSTAL Renal Denervation Global Clinical Study

Cardiovascular Diseases | Vascular Diseases | Hypertension

United States, United Kingdom, Germany, Greece
Medtronic Vascular

Active, not recruiting

SPYRAL HTN-ON MED Study of Renal Denervation With the Symplicity Spyral™ Multi-electrode Renal Denervation System

Cardiovascular Diseases | Vascular Diseases | Hypertension

United States, Germany, Canada, Australia, United Kingdom, France, Ireland, Japan, Austria, Greece
Medtronic Vascular

Active, not recruiting

RESOLUTE ONYX China Single Arm Study

Cardiovascular Diseases | Coronary Artery Disease | Arteriosclerosis | Ischemic Heart Disease | Stenotic Coronary Lesion

China
Medtronic Vascular

Completed

Renal Nerve Denervation in Patients With Hypertension and Paroxysmal and Persistent Atrial Fibrillation (Symplicity AF)

Hypertension | Atrial Fibrillation

United States, Germany
Medtronic Vascular

Completed

RESOLUTE ONYX Post-Approval Study (Bifurcation Cohort)

Coronary Artery Disease

United States, Belgium, France, Slovakia
Medtronic Vascular

Completed

Bare Metal Bifurcation Stent Clinical Trial in Humans (BRANCH)

Myocardial Ischemia | Coronary Artery Disease

New Zealand
Medtronic Vascular

Completed

SYMPLICITY HTN-3 Renal Denervation in Patients With Uncontrolled Hypertension

Uncontrolled Hypertension

United States
Medtronic Vascular

Completed

Renal Denervation in Patients With Uncontrolled Hypertension - SYMPLICITY HTN-4 (HTN-4)

Cardiovascular Diseases | Vascular Diseases | Hypertension

United States
Medtronic Vascular

Terminated

Renal Denervation in Patients With Chronic Heart Failure & Renal Impairment Clinical Trial (SymplicityHF)

Heart Failure

Australia
Medtronic Vascular

Completed

Multi-electrode Radiofrequency Renal Denervation System Feasibility Study

Uncontrolled Hypertension

Australia, New Zealand
Medtronic Vascular

Completed

Acute Safety, Deliverability and Efficacy of the Medtronic Resolute Integrity™ Zotarolimus-Eluting Coronary Stent System in the Treatment of Suitable Patients According to Indication for Use (CHINA RESOLUTE INTEGRITY STUDY)

Cardiovascular Diseases | Coronary Artery Disease | Arteriosclerosis | Ischemic Heart Disease

China
Medtronic Vascular

Completed

EDUCATE: The MEDTRONIC Endeavor Drug Eluting Stenting: Understanding Care, Antiplatelet Agents and Thrombotic Events (EDUCATE)

Coronary Artery Disease

United States
Medtronic Vascular

Completed

Endeavor Zotarolimus - Eluting Stent in the Treatment Lesions in Small Native Coronary Arteries. (ENDEAVORSVS)

Coronary Artery Disease

United States
Medtronic Vascular

Completed

Renal Denervation in Patients With Refractory Hypertension

Hypertension

United States
Medtronic Vascular

Completed

Renal Denervation in Patients With Refractory Hypertension (HTN-1)

Hypertension

Germany
Medtronic Vascular

Completed

Native Kidney Denervation in Patients With End Stage Renal Disease

End Stage Renal Disease

Australia, Poland
Lake Washington Vascular
Medtronic Vascular

Unknown

Lake Washington Vascular VenaSeal™ Post-Market Evaluation (New-WAVES)

Varicose Veins | Venous Reflux

United States
Medtronic Vascular
Medtronic Japan Co., Ltd.

Completed

RESOLUTE Japan - The Clinical Evaluation of the MDT-4107 Drug-Eluting Coronary Stent (RJ)

Myocardial Ischemia | Cardiovascular Diseases | Coronary Artery Disease | Arterial Occlusive Diseases

Japan

Clinical Trials Sponsored by Medtronic Vascular

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Costa Rica

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations